These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29695290)

  • 41. Current Status of Hybrid PET/MRI in Oncologic Imaging.
    Rosenkrantz AB; Friedman K; Chandarana H; Melsaether A; Moy L; Ding YS; Jhaveri K; Beltran L; Jain R
    AJR Am J Roentgenol; 2016 Jan; 206(1):162-72. PubMed ID: 26491894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
    Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
    Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between the size of incidental thyroid nodules detected on CT, MRI or PET-CT and subsequent ultrasound.
    Ní Mhuircheartaigh JM; Siewert B; Sun MR
    Clin Imaging; 2016; 40(6):1162-1166. PubMed ID: 27569401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas.
    Chauhan D; Rawat S; Sharma MK; Ahlawat P; Pal M; Gupta G; Dewan A; Gupta M; Sharma S; Dodagoudar C; Pahuja A; Mitra S; Sharma SK
    J Cancer Res Ther; 2015; 11(4):746-51. PubMed ID: 26881512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Comparison of Radiologists' and Urologists' Opinions Regarding Prostate MRI Reporting: Results From a Survey of Specialty Societies.
    Spilseth B; Ghai S; Patel NU; Taneja SS; Margolis DJ; Rosenkrantz AB
    AJR Am J Roentgenol; 2018 Jan; 210(1):101-107. PubMed ID: 29064758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET/MRI: Emerging Clinical Applications in Oncology.
    Fraum TJ; Fowler KJ; McConathy J
    Acad Radiol; 2016 Feb; 23(2):220-36. PubMed ID: 26521689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of small lung nodules missed on hybrid PET/MRI in patients with primary malignancy.
    Raad RA; Friedman KP; Heacock L; Ponzo F; Melsaether A; Chandarana H
    J Magn Reson Imaging; 2016 Feb; 43(2):504-11. PubMed ID: 26192731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is integrated 18F-FDG PET/MRI superior to 18F-FDG PET/CT in the differentiation of incidental tracer uptake in the head and neck area?
    Schaarschmidt BM; Gomez B; Buchbender C; Grueneisen J; Nensa F; Sawicki LM; Ruhlmann V; Wetter A; Antoch G; Heusch P
    Diagn Interv Radiol; 2017; 23(2):127-132. PubMed ID: 28089955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
    Dyrberg E; Larsen EL; Hendel HW; Thomsen HS
    Acta Radiol; 2018 Sep; 59(9):1119-1125. PubMed ID: 29313360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hybrid imaging for pancreatic malignancy: clinical applications, merits, limitations, and pitfalls.
    Jha P; Bijan B; Melendres G; Shelton DK
    Clin Nucl Med; 2015 Mar; 40(3):206-13. PubMed ID: 25608151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hybrid Positron Emission Tomography/Magnetic Resonance Imaging: Challenges, Methods, and State of the Art of Hardware Component Attenuation Correction.
    Paulus DH; Quick HH
    Invest Radiol; 2016 Oct; 51(10):624-34. PubMed ID: 27175550
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear Medicine Technologists' Perception and Current Assessment of Quality: A Society of Nuclear Medicine and Molecular Imaging Technologist Section Survey.
    Mann A; Farrell MB; Williams J; Basso D
    J Nucl Med Technol; 2017 Jun; 45(2):67-74. PubMed ID: 28473461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early
    Domachevsky L; Bernstine H; Goldberg N; Nidam M; Stern D; Sosna J; Groshar D
    Clin Radiol; 2017 Nov; 72(11):944-950. PubMed ID: 28716214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relative value of three whole-body MR approaches for PET-MR, including gadofosveset-enhanced MR, in comparison to PET-CT.
    Obara P; Loening A; Taviani V; Iagaru A; Hargreaves BA; Vasanawala S
    Clin Imaging; 2018; 48():62-68. PubMed ID: 29031209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hybrid (CT/MRI based) vs. MRI only based image-guided brachytherapy in cervical cancer: Dosimetry comparisons and clinical outcome.
    Choong ES; Bownes P; Musunuru HB; Rodda S; Richardson C; Al-Qaisieh B; Swift S; Orton J; Cooper R
    Brachytherapy; 2016; 15(1):40-8. PubMed ID: 26602964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The implication of the shortage of health workforce specialist on universal health coverage in Kenya.
    Miseda MH; Were SO; Murianki CA; Mutuku MP; Mutwiwa SN
    Hum Resour Health; 2017 Dec; 15(1):80. PubMed ID: 29191247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hybrid
    Goorts B; Vöö S; van Nijnatten TJA; Kooreman LFS; de Boer M; Keymeulen KBMI; Aarnoutse R; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1796-1805. PubMed ID: 28600647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.